U.S. flag

An official website of the United States government

NM_013275.6(ANKRD11):c.3632_3633del (p.Lys1211fs) AND KBG syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jun 24, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000500373.8

Allele description [Variation Report for NM_013275.6(ANKRD11):c.3632_3633del (p.Lys1211fs)]

NM_013275.6(ANKRD11):c.3632_3633del (p.Lys1211fs)

Gene:
ANKRD11:ankyrin repeat domain containing 11 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
16q24.3
Genomic location:
Preferred name:
NM_013275.6(ANKRD11):c.3632_3633del (p.Lys1211fs)
HGVS:
  • NC_000016.10:g.89282910_89282911del
  • NG_032003.2:g.212652_212653del
  • NM_001256182.2:c.3632_3633del
  • NM_001256183.2:c.3632_3633del
  • NM_013275.6:c.3632_3633delMANE SELECT
  • NP_001243111.1:p.Lys1211fs
  • NP_001243112.1:p.Lys1211fs
  • NP_037407.4:p.Lys1211fs
  • NC_000016.9:g.89349318_89349319del
  • NG_032003.1:g.212652_212653del
  • NM_013275.5:c.3632_3633del
  • NM_013275.5:c.3632_3633delAA
Protein change:
K1211fs
Links:
dbSNP: rs1555528400
NCBI 1000 Genomes Browser:
rs1555528400
Molecular consequence:
  • NM_001256182.2:c.3632_3633del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001256183.2:c.3632_3633del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_013275.6:c.3632_3633del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
KBG syndrome (KBGS)
Synonyms:
Short stature, characteristic facies, macrodontia, mental retardation, and skeletal anomalies
Identifiers:
MONDO: MONDO:0007846; MedGen: C0220687; Orphanet: 2332; OMIM: 148050

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000593189Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 16, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002557663Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jun 24, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

KBG syndrome.

Morel Swols D, Foster J 2nd, Tekin M.

Orphanet J Rare Dis. 2017 Dec 19;12(1):183. doi: 10.1186/s13023-017-0736-8. Review.

PubMed [citation]
PMID:
29258554
PMCID:
PMC5735576

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Genetic Services Laboratory, University of Chicago, SCV000593189.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV002557663.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with KBG syndrome (MIM#148050). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. Intra-familial variability has been reported (PMID: 29258554). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant has been reported once as pathogenic (ClinVar). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 9, 2023